Contents

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Volume 2 - Number 4

Efficacy of Enzyme Replacement Therapy in Fabry Disease

, 2(4): 277 - 286

F. Barbey, D. Hayoz, U. Widmer and M. Burnier


DOI: 10.2174/1568016043356192




Mineralocorticoid Receptor Antagonism and Cardiac Remodeling in Ischemic Heart Failure

, 2(4): 287 - 294

D. Fraccarollo, P. Galuppo and J. Bauersachs


DOI: 10.2174/1568016043356219




Emerging Technologies in Biocompatible Surface Modifying Additives: Quest for Physiologic Cardiopulmonary Bypass

, 2(4): 295 - 302

Serdar Gunaydin


DOI: 10.2174/1568016043356237




α2-Antiplasmin: Potential Therapeutic Roles in Fibrin Survival and Removal

, 2(4): 303 - 310

Kyung N. Lee, Kenneth W. Jackson, Victoria J. Christiansen, Keun H. Chung and Patrick A. McKee


DOI: 10.2174/1568016043356228




Novel Antithrombotic Agents: Indirect Synthetic Inhibitors of Factor Xa and Direct Thrombin Inhibitors. Evidences from Clinical Studies

, 2(4): 311 - 326

Giuseppe Leone, Elena Rossi, Antonio Maria Leone and Valerio De Stefano


DOI: 10.2174/1568016043356183




Atherosclerosis - New Targets and Therapeutics

, 2(4): 327 - 334

Sivaram Pillarisetti, Christopher W. Alexander and Uday Saxena


DOI: 10.2174/1568016043356246




Urocortins: Take Them to Heart

, 2(4): 335 - 342

Tiziano Scarabelli and Richard Knight


DOI: 10.2174/1568016043356174




Salutary Properties of YC-1 in the Cardiovascular and Hematological Systems

, 2(4): 343 - 359

David Anthony Tulis


DOI: 10.2174/1568016043356200




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science